GMP Archives - Dipharma

Dipharma granted first CADIFA by Brazilian ANVISA for the Ursodeoxycholic Acid

Panel discussion on Custom synthesis & Contract manufacturing

dipharma_paola2024-10-15T15:48:58+00:00October 15th, 2024|

Dipharma Francis S.r.l., the Shareholders’ Meeting Appoints the New Board of Directors

Panel discussion on Custom synthesis & Contract manufacturing

dipharma_paola2024-05-22T16:48:19+00:00May 22nd, 2024|

Successful FDA Inspection at Dipharma Facility in Kalamazoo, MI, USA

Panel discussion on Custom synthesis & Contract manufacturing

dipharma_paola2024-05-08T12:21:13+00:00May 7th, 2024|

Dipharma receives the 2nd GMP Certification from Brazilian ANVISA

Panel discussion on Custom synthesis & Contract manufacturing

dipharma_paola2023-10-26T10:48:50+00:00October 26th, 2023|

Dipharma expands its Italian R&D Center
to increase its analytical services

Panel discussion on Custom synthesis & Contract manufacturing

dipharma_paola2023-04-04T17:15:15+00:00April 4th, 2023|

Dipharma completes second phase of CGMP expansion at its Kalamazoo site

Panel discussion on Custom synthesis & Contract manufacturing

dipharma_paola2023-02-10T15:48:00+00:00February 10th, 2023|

Dipharma receives GMP certification from Brazilian ANVISA

Panel discussion on Custom synthesis & Contract manufacturing

dipharma_paola2022-12-01T13:57:46+00:00December 1st, 2022|

Regulatory authorization for the new line at cGMP pilot plant

Panel discussion on Custom synthesis & Contract manufacturing

dipharma_paola2022-12-22T16:54:02+00:00October 6th, 2022|